TROPHIC FACTORS FOR STIMULATING NERVOUS SYSTEM REGENERATION Russian patent published in 2000 - IPC

Abstract RU 2157223 C2

FIELD: medicine. SUBSTANCE: method involves culturing cells supporting life activity of retina neurons under known conditions without blood serum. Molecular factors are used for stimulating axon-type regeneration from this kind of neurons. Glial envelope cells surrounding optic nerve axons issue two molecules initiating and supporting nerve regeneration. One molecule is called axogenesis factor 1 being low molecular mass polypeptide which size is in the vicinity of 1000 Dalton that is equivalent of 707 Dalton according to mass spectroscopy study data. The second molecule is called axogenesis factor 2 being large size protein of approximately 12000 Dalton in size. The factors are included strictly into the central nervous system regeneration, and are useable for treating spinal cord injuries and other injures of nerve tissues. EFFECT: enhanced effectiveness of treatment. 4 cl, 4 dwg

Similar patents RU2157223C2

Title Year Author Number
METHOD FOR MODULATING AND METHOD FOR STIMULATING GROWTH CENTRAL NERVOUS SYSTEM NEURON AXONS AND FOR TREATING FOR INSULT AND PACKED PHARMACEUTICAL PREPARATION 1998
  • Benouits Larri I.
RU2212241C2
APPLICATION OF (2-IMIDAZOLIN-2-YLAMINO) QUINOXALINES IN DEMENTIA AND PARKINSON'S DISEASE TREATMENT 2003
  • Tatton Vil'Jam G.
  • Viler Larri A.
  • Dzhil Dehniehl V.
  • Donello Dzhon E.
RU2332218C2
IMMUNOGENIC COMPOSITIONS OF MULTIPLE ANTIGEN PRESENTATION, METHODS AND APPLICATIONS RELATING THERETO 2012
  • Molli Richard
  • Lu Intsze
  • Chzan Fan
RU2619176C2
MODIFIED BIOTIN-BINDING PROTEIN, FUSION PROTEINS BASED THEREON AND THEIR APPLICATION 2012
  • Molli Richard
  • Lu Intsze
  • Chzan Fan
RU2632651C2
GLAUCOMA TREATMENT 2018
  • Bruce Lars
  • Bruce Adam
RU2759998C2
METHOD FOR PRODUCING DRUG USED FOR TREATING GASTROINTESTINAL ULCER IN MAMMALS 1990
  • Folkman Mozes Dzh.[Us]
  • Kato Koiti[Jp]
RU2020931C1
AGENTS ADJUSTING, INHIBITING OR MODULATING ACTIVITY AND/OR EXPRESSION OF CONNECTIVE TISSUE GROWTH FACTORS (CTGF) AS UNIQUE DRUGS FOR INTRAOCULAR TENSION REDUCTION AND TREATMENT OF GLAUCOMA RETINOPATHIES/OPTICAL NEUROPATHIES 2003
  • Flinor Debra L.
  • Shepard Allan
  • Dzhejkobson Nasrin
  • Pan Iok-Khou
  • Klark Ehbbot F.
RU2332213C2
METHODS FOR MAKING POLYCLONAL ANTIBODIES, ANTISERUM CONTAINING POLYCLONAL ANTIBODIES, AND METHODS FOR IMMUNISATION 1999
  • Shvab Martin Eh.
  • Chen Majo S.
RU2358982C2
PURIFIED IMMUNOGENIC PROTEIN, ITS FRAGMENTS AND DERIVATIVES 1999
  • Shvab Martin Eh.
  • Chen Majo S.
RU2304585C2
GENE-CELL VESICULAR THERAPEUTIC DRUG AND METHOD FOR MULTIPLE SCLEROSIS THERAPY BY TRANSPLANTATION OF A GENE-CELL VESICULAR THERAPEUTIC DRUG 2021
  • Arkhipova Svetlana Sergeevna
  • Alatrash Rim
  • Garanina Ekaterina Evgenevna
  • Rizvanov Albert Anatolevich
RU2762855C1

RU 2 157 223 C2

Authors

Larri I.Benovits

Karlin A.Irvin

Pol Dzhekson

Dates

2000-10-10Published

1995-08-24Filed